$117 Million is the total value of Velan Capital Investment Management LP's 31 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 280.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | JASPER THERAPEUTICS INC | $19,617,289 | +1331.3% | 11,219,036 | +248.5% | 16.72% | +1280.8% | |
| HRTX | Buy | HERON THERAPEUTICS INC | $6,795,000 | +8.7% | 4,500,000 | +80.0% | 5.79% | +4.9% |
| FEZ | New | SPDR INDEX SHS FDSput | $4,490,000 | – | 100,000 | +100.0% | 3.83% | – |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $4,194,665 | – | 5,185,000 | +100.0% | 3.58% | – |
| THC | Buy | TENET HEALTHCARE CORP | $3,083,898 | +26.4% | 51,900 | +3.8% | 2.63% | +22.0% |
| GRTX | New | GALERA THERAPEUTICS INC | $2,560,000 | – | 1,000,000 | +100.0% | 2.18% | – |
| CABA | New | CABALETTA BIO INC | $2,067,500 | – | 250,000 | +100.0% | 1.76% | – |
| ETNB | New | 89BIO INC | $1,500,155 | – | 98,500 | +100.0% | 1.28% | – |
| TERN | Buy | TERNS PHARMACEUTICALS INC | $1,420,800 | +1211.0% | 120,000 | +1027.2% | 1.21% | +1161.5% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $1,344,200 | – | 220,000 | +100.0% | 1.15% | – |
| EDSA | Buy | EDESA BIOTECH INC | $1,168,961 | -39.1% | 1,281,615 | +44.2% | 1.00% | -41.3% |
| New | THESEUS PHARMACEUTICALS INC | $888,000 | – | 100,000 | +100.0% | 0.76% | – | |
| New | ICOSAVAX INC | $870,000 | – | 150,000 | +100.0% | 0.74% | – | |
| GERN | New | GERON CORP | $651,000 | – | 300,000 | +100.0% | 0.56% | – |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $500,526 | – | 23,400 | +100.0% | 0.43% | – | |
| ANNX | New | ANNEXON INC | $385,000 | – | 100,000 | +100.0% | 0.33% | – |
| New | DISC MEDICINE INC | $259,980 | – | 12,269 | +100.0% | 0.22% | – | |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $235,806 | – | 25,743 | +100.0% | 0.20% | – |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $194,600 | – | 140,000 | +100.0% | 0.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LANTHEUS HLDGS INC | 8 | Q3 2023 | 18.0% |
| ADMA BIOLOGICS INC | 8 | Q3 2023 | 13.7% |
| JASPER THERAPEUTICS INC | 8 | Q3 2023 | 17.8% |
| TELA BIO INC | 8 | Q3 2023 | 7.6% |
| REZOLUTE INC | 8 | Q3 2023 | 1.3% |
| OPTINOSE INC | 7 | Q3 2023 | 7.9% |
| IMMUNOCORE HLDGS PLC | 6 | Q1 2023 | 13.7% |
| ALIMERA SCIENCES INC | 6 | Q3 2023 | 34.0% |
| QUIPT HOME MEDICAL CORP | 6 | Q3 2023 | 4.8% |
| SONIDA SENIOR LIVING INC | 6 | Q1 2023 | 2.5% |
View Velan Capital Investment Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-03-28 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-09 |
| SC 13D/A | 2024-02-09 |
| SC 13G/A | 2024-01-29 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-04 |
| 4 | 2023-08-17 |
| SC 13D/A | 2023-08-16 |
| 13F-HR | 2023-08-11 |
View Velan Capital Investment Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.